JEROME STENEHJEM: Open Payments
NPI 1790992279 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 8 payments from 6 companies in 2025. Trend: 2023 $337 · 2024 $235 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $65 |
| SCILEX PHARMACEUTICALS INC. | 2 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
Products named: Dysport, ELYXYB - CELECOXIB, JOURNAVX, XTAMPZA, UBRELVY, QUTENZA.
Industry payments across CA — which companies pay providers there.
